Xtx Topco LTD Veru Inc. Transaction History

Xtx Topco LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.37 - $0.72 $32,754 - $63,738	88,526 New	88,526 $61,000
Q2 2023 Aug 14, 2023	BUY	$0.98 - $1.49 $25,942 - $39,443	26,472 New	26,472 $31,000
Q4 2022 Feb 14, 2023	BUY	$4.78 - $15.01 $432,872 - $1.36 Million	90,559 Added 317.01%	119,126 $628,000
Q3 2022 Nov 14, 2022	BUY	$10.22 - $23.7 $291,954 - $677,037	28,567 New	28,567 $329,000
Q2 2022 Aug 15, 2022	SELL	$4.35 - $15.85 $62,753 - $228,652	-14,426 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$4.55 - $6.41 $10,328 - $14,550	2,270 Added 18.67%	14,426 $70,000
Q4 2021 Feb 11, 2022	BUY	$5.89 - $9.73 $71,598 - $118,277	12,156 New	12,156 $72,000

123

56.9M

668K

531K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $56.9M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.